← Leaderboards
John Gerard Purdy
University Of Arizona
$4,395,670
Attributed
$5,811,762
Total exposure
3
Grants
2
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $1.5M · FY2021–25$2M$1.5M$1M$500K$0
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$5,811,762 · 3
By mechanism
R01$5,811,762 · 3
Top collaborators
- Richard M Green4 shared
- Jason A Wertheim4 shared
Most similar at University Of Arizona
Same institution · by research overlap
- Frank Anthony Duca$3,300,529
- Felicia D Goodrum$17,339,452
- A F Philipps$145,494
- Michael W Nachman$2,239,724
Others in their field
Other Emerging Leaders on “Biology”
- Sonia M Thomas · Research Triangle Institute$700,865,642
- Tracy L Nolen · Research Triangle Institute$474,487,152
- Leonard Freedman · Leidos Biomedical Research, Inc.$377,088,269
- Ethan Dmitrovsky · Leidos Biomedical Research, Inc.$343,713,561
- Chanza Baytop · Westat, Inc.$271,217,917
- Lynn Briscoe · Leidos Biomedical Research, Inc.$149,803,496
Research focus
BiologyMetabolicSignal TransductionProteinsCellsResponseBiological ProcessSignal PathwayViralVirusMolecularMetabolismVirus Host InteractionDisabilityEnzymesBindingCytomegalovirusInfectionCrispr/Cas TechnologyVirus ReplicationPathogenesisPathway InteractionsMetabolomicsLipidomics
Grant awards (14)
Ex-vivo bioengineered technology to unravel dysfunction due to non-alcoholic steatohepatitis (NASH)$686,972
R01 · FY2025 · DK
Mechanisms of Human Cytomegalovirus Reprogramming of Lipid Metabolism$366,372
R01 · FY2025 · AI · contact PI
Metabolite-mediated Signaling in Cell-to-Cell Spread of Human Cytomegalovirus$366,372
R01 · FY2025 · AI · contact PI
Ex-vivo bioengineered technology to unravel dysfunction due to non-alcoholic steatohepatitis (NASH)$76,964
R01 · FY2025 · DK
Ex-vivo bioengineered technology to unravel dysfunction due to non-alcoholic steatohepatitis (NASH)$659,671
R01 · FY2024 · DK
Metabolite-mediated Signaling in Cell-to-Cell Spread of Human Cytomegalovirus$367,659
R01 · FY2024 · AI · contact PI
Mechanisms of Human Cytomegalovirus Reprogramming of Lipid Metabolism$367,659
R01 · FY2024 · AI · contact PI
Ex-vivo bioengineered technology to unravel dysfunction due to non-alcoholic steatohepatitis (NASH)$700,531
R01 · FY2023 · DK
Mechanisms of Human Cytomegalovirus Reprogramming of Lipid Metabolism$368,851
R01 · FY2023 · AI · contact PI
Metabolite-mediated Signaling in Cell-to-Cell Spread of Human Cytomegalovirus$368,851
R01 · FY2023 · AI · contact PI
Mechanisms of Human Cytomegalovirus Reprogramming of Lipid Metabolism$369,954
R01 · FY2022 · AI · contact PI
Metabolite-mediated Signaling in Cell-to-Cell Spread of Human Cytomegalovirus$369,954
R01 · FY2022 · AI · contact PI
Mechanisms of Human Cytomegalovirus Reprogramming of Lipid Metabolism$370,976
R01 · FY2021 · AI · contact PI
Metabolite-mediated Signaling in Cell-to-Cell Spread of Human Cytomegalovirus$370,976
R01 · FY2021 · AI · contact PI